Clinical Trials Browser

Phase 1/2 × INDUSTRY × donafenib × Clear all

NCT06239298 2024-06-14

A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT02489201 2023-06-15

A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms

NCT02489214 2023-05-08

Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer

Phase 1/2 Terminated

Gastrointestinal

Stomach Neoplasms

NCT02698111 2023-05-08

Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma

Phase 1/2 Terminated

Nasopharyngeal Carcinoma

NCT02489916 2016-01-05

Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms